Latest Breaking News On - Sound pharmaceuticals - Page 1 : comparemela.com

Sound Pharmaceuticals IND Involving Cochlear Implantation Allowed by the FDA

SEATTLE & INNSBRUCK, Austria, May 20, 2024 Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI). The goal of this Phase 2 SPI-1005 (ebselen) trial is to reduce the loss of residual hearing during and after CI. Ebselen is a novel anti-inflammatory compound that mimics and induces the activity of Glutathione Peroxidase, an enzyme that is c

United statesJonathan kilNicola trussellErwin hochmairCystic fibrosis foundationPr corporate communicationsSound pharmaceuticalsInvestigational new drug applicationGlutathione peroxidaseFast trackPrincipal investigatorCystic fibrosis

SPI-1005 may help prevent ear damage due to CF antibiotics use

SPI-1005 may help prevent ear damage due to CF antibiotics use
cysticfibrosisnewstoday.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from cysticfibrosisnewstoday.com Daily Mail and Mail on Sunday newspapers.

United statesJonathan kilAssociation for researchCystic fibrosis foundationSound pharmaceuticalsMidwinter meetingCystic fibrosis

Vertigo Drugs Market to grow by USD 551 42 million from 2022-2027, North America to account for 38% of market growth

/PRNewswire/ The vertigo drugs market size is expected to grow by USD 551.42 million from 2022 to 2027. In addition, the momentum of the market will.

United kingdomSouth africaUnited statesIndicus pharmaJesse maidaAdvacare pharmaLupin ltdIntas pharmaceuticals ltdAltamira therapeutics ltdJubilant pharmova ltdOtonomy incTechnavio researchEndo international plcF hoffmann la roche ltdCompany analysisSuven life sciences ltd

Vertigo Drugs Market To Grow By Usd 551 42 Million From 2022-2027, North America To Account For 38% Of Market Growth - Technavio

Vertigo Drugs Market To Grow By Usd 551 42 Million From 2022-2027, North America To Account For 38% Of Market Growth - Technavio
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesSouth africaUnited kingdomAdvacare pharmaJesse maidaSun pharmaceutical industries ltdSuven life sciences ltdAltamira therapeutics ltdAmneal pharmaceuticals incEpic pharmaOtonomy incF hoffmann la roche ltdViatris incGlaxosmithkline plcCompany landscapeTechnavio research

DelveInsight Evaluates a Robust Cystic Fibrosis Pipeline as 75+ Influential Pharma Players to Set Foot in the Domain

Cystic fibrosis is quickly becoming the most prevalent genetic illness in every region of the world. According to the Cystic Fibrosis Patient Registry, more.

United statesShruti thakurVerona pharmaPrnewswire delveinsightChiesi farmaceuticiBranca bunUniversity collaborations licensing partnering analysisTherapeutics assessmentby route of administrationIonis pharmaceuticals incBoehringer ingelheimAridis pharmaceuticals incVertex pharmaceuticalsSanthera pharmaceuticalsDrug administrationCf foundationBio inc